Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 2/2016

Open Access 01-04-2016 | Research Article

Clinical and conventional pharmacy services in Polish hospitals: a national survey

Authors: Iga Pawłowska, Leszek Pawłowski, Ivan Kocić, Natalia Krzyżaniak

Published in: International Journal of Clinical Pharmacy | Issue 2/2016

Login to get access

Abstract

Background Pharmacist-led care services within the hospital pharmacy setting have a significant impact on efficient drug management processes. The work of pharmacists is directly associated with the provision of drugs and medical supplies along with additional clinical, administrative, organizational and educational duties. Depending on the country, these practice roles may differ to a significant extent. Objective The aim of this research was to explore the role of the hospital pharmacist and the provision of both clinical and traditional pharmaceutical services for patients and medical staff in Polish general hospitals. Setting Hospital pharmacies from all general hospitals in Poland. Method A cross-sectional study was conducted, utilizing an anonymous questionnaire as the research instrument. Heads of hospital pharmacies were requested to participate in this study and complete the questionnaire. The survey was initially piloted to improve the research method. Main outcome measure The types of pharmaceutical services performed in Polish general hospitals. Results 166 hospital pharmacies took part in this survey. The overall response rate was 60.8 %. The total number of full-time equivalent (FTE) professionals employed within the surveyed hospital pharmacies was approximately 833. The procurement and distribution of drugs were identified as pharmaceutical services performed by most of the participants. The significant majority of pharmacists were also involved in compounding, adverse drug reaction monitoring and rational drug management services. Eleven (7 %) of the responding pharmacists had direct contact with patients and 7 (4 %) pharmacists took part in ward rounds. More precise legal regulations regarding hospital pharmacy practice were measures indicated by most pharmacists as necessary changes required in the hospital pharmacy system. Conclusion Polish hospital pharmacists provide various pharmaceutical services. Their work is closely related with direct provision of drugs. There is an observed inadequate level of clinical services provided in comparison to clinical settings in other countries.
Appendix
Available only for authorised users
Literature
1.
The European Statements of Hospital Pharmacy. Eur J Hosp Pharm. 2014;21:256–58.
2.
Campbell G, Auyeung V, McRobbie G. Clinical pharmacy services in a London hospital, have they changed? Int J Clin Pharm. 2013;35:688–91.CrossRefPubMed
3.
4.
Frontini R, Miharija-Gala T, Sykora J. Survey. EAHP survey 2010 on hospital pharmacy in Europe: parts 4 and 5. Clinical services and patient safety. Eur J Hosp Pharm. 2013;20:69–73.CrossRef
5.
Horn E, Jacobi J. The critical care clinical pharmacist: evolution of an essential team member. Crit Care Med. 2006;34(3 Suppl):46–51.CrossRef
6.
Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29(5):691–8.CrossRefPubMed
7.
Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894–900.CrossRefPubMed
8.
Shah S, Dowell J, Greene S. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting. Ann Pharmacother. 2006;40(9):1527–33.CrossRefPubMed
9.
Cabello-Muriel A, Gascón-Cánovas JJ, Urbieta-Sanz E, Iniesta-Navalón C. Effectiveness of pharmacist intervention in patients with chronic kidney disease. Int J Clin Pharm. 2014;36(5):896–903.CrossRefPubMed
10.
Hassali MA, Nazir SU, Saleem F, Masood I. Literature review: pharmacists’ interventions to improve control and management in type 2 diabetes mellitus. Altern Ther Health Med. 2015;21(1):28–35.PubMed
11.
Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med. 2002;30(4):919–21.CrossRefPubMed
12.
Al-Jazairi AS, Al-Agil AA, Asiri YA, Al-Kholi TA, Akhras NS, Horanieh BK. The impact of clinical pharmacist in a cardiac-surgery intensive care unit. Saudi Med J. 2008;29(2):277–81.PubMed
13.
Kwan Y, Fernandes OA, Nagge JJ, Wong GG, Huh JH, Hurn DA, et al. Pharmacist medication assessments in a surgical preadmission clinic. Arch Intern Med. 2007;167(10):1034–40.CrossRefPubMed
14.
Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159(16):1939–45.CrossRefPubMed
15.
Lucas C, Glare PA, Sykes JV. Contribution of a liaison clinical pharmacist to an inpatient palliative care unit. Palliat Med. 1997;11(3):209–16.CrossRefPubMed
16.
Rothschild JM, Churchill W, Erickson A, Munz K, Schuur JD, Salzberg CA, et al. Medication errors recovered by emergency department pharmacists. Ann Emerg Med. 2010;55(6):513–21.CrossRefPubMed
17.
Wang JK, Herzog NS, Kaushal R, Park C, Mochizuki C, Weingarten SR. Prevention of pediatric medication errors by hospital pharmacists and the potential benefit of computerized physician order entry. Pediatrics. 2007;119(1):e77–85.CrossRefPubMed
18.
Vasileff HM, Whitten LE, Pink JA, Goldsworthy SJ, Angley MT. The effect on medication errors of pharmacists charting medication in an emergency department. Pharm World Sci. 2009;31(3):373–9.CrossRefPubMed
19.
Gheewala PA, Peterson GM, Curtain CM, Nishtala PS, Hannan PJ, Castelino RL. Impact of the pharmacist medication review services on drug-related problems and potentially inappropriate prescribing of renally cleared medications in residents of aged care facilities. Drugs Aging. 2014;31(11):825–35.CrossRefPubMed
20.
Williams SD, Phipps DL, Ashcroft DM. Understanding the attitudes of hospital pharmacists to reporting medication incidents: a qualitative study. Res Social Adm Pharm. 2013;9(1):80–9.CrossRefPubMed
21.
Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy. 2009;29(12):1433–40.CrossRefPubMed
22.
Phansalkar S, Hoffman JM, Hurdle JF, Patel VL. Understanding pharmacist decision making for adverse drug event (ADE) detection. J Eval Clin Pract. 2009;15(2):266–75.CrossRefPubMedPubMedCentral
23.
Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51(1):81–6.CrossRefPubMedPubMedCentral
24.
Gerdemann A, Griese N, Schulz M. Pharmacy interns on the ward—a pilot study. Pharm World Sci. 2007;29:34–8.CrossRefPubMed
25.
Ombaka E. Current status of medicines procurement. Am J Health Syst Pharm. 2009;66(5 Suppl 3):20–8.CrossRef
26.
Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: dispensing and administration–2011. Am J Health Syst Pharm. 2012;69(9):768–85.CrossRefPubMed
27.
Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: dispensing and administration—2008. Am J Health Syst Pharm. 2008;66(10):926–46.CrossRef
28.
Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: dispensing and administration—2005. Am J Health Syst Pharm. 2006;63(4):327–45.CrossRefPubMed
29.
30.
Frontini R, Miharija-Gala T, Sykora J. EAHP, Survey 2010 on hospital pharmacy in Europe: part 3. Production and quality assurance. Eur J Hosp Pharm. 2012;19:510–3.CrossRef
31.
Pawłowska I, Kocić I. Rational use of medicines in the hospitals of Poland: role of the pharmacists. Eur J Hosp Pharm. 2014;21:372–7.CrossRef
32.
Frontini R, Miharija-Gala T, Sykora J. EAHP, Survey 2010 on hospital pharmacy in Europe: Part 1. General frame and staffing. Eur J Hosp Pharm. 2012;19:385–7.CrossRef
33.
Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing—2013. Am J Health Syst Pharm. 2014;71(11):924–42.CrossRefPubMed
34.
Merks P, Sawicka A, Kozłowska-Wojciechowska M. Rola apteki szkoleniowej WUM w edukacji przyszłych pokoleń farmaceutów. Farm Pol. 2014;70(2):84–8.
35.
Directive 2005/36/Ec of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications.
36.
Gillespie U, Mörlin C, Hammarlund-Udenaes M, Hedström M. Perceived value of ward-based pharmacists from the perspective of physicians and nurses. Int J Clin Pharm. 2012;34(1):127–35.CrossRefPubMed
37.
Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care. 2005;14(3):207–11.CrossRefPubMedPubMedCentral
38.
Tan EL, Day RO, Brien JA. Perspectives on drug and therapeutics committee policy implementation. Res Social Adm Pharm. 2005;1(4):526–45.CrossRefPubMed
39.
Fijn R, Brouwers JR, Knaap RJ, De Jong-Van Den Berg LT. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures. Br J Clin Pharmacol. 1999;48(2):239–46.CrossRefPubMedPubMedCentral
40.
Chisholm-Burns M, Graff Zivin J, Lee J, Spivey C, Slack M, Herrier R, et al. Economic effects of pharmacists on health outcomes in the United States: a systematic review. Am J Health Syst Pharm. 2010;67:1624–34.CrossRefPubMed
41.
Weant K, Armitstead J, Ladha A, Sasaki-Adams D, Hadar E, Ewend M. Cost effectiveness of a clinical pharmacist on a neurosurgical team. Neurosurgery. 2009;65:946–50.CrossRefPubMed
42.
von Gunten V, Reymond J, Beney J. Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review. Pharm World Sci. 2007;29:146–63.CrossRef
Metadata
Title
Clinical and conventional pharmacy services in Polish hospitals: a national survey
Authors
Iga Pawłowska
Leszek Pawłowski
Ivan Kocić
Natalia Krzyżaniak
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 2/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0234-9

Other articles of this Issue 2/2016

International Journal of Clinical Pharmacy 2/2016 Go to the issue

Short Research Report

Consumption of medicinal plants by patients with heart diseases at a pharmacist-managed anticoagulation clinic in Brazil

Short Research Report

Who uses pharmacy for flu vaccinations? Population profiling through a UK pharmacy chain

Research Article

Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar

Research Article

Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction

Erratum

Erratum to: Medical care and drug-related problems: Do doctors and pharmacists speak the same language?

Research Article

Assessing the relationship between pharmacists’ job satisfaction and over-the-counter counselling at community pharmacies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits